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Acute kidney dysfunction after ischemia–reperfusion injury
(IRI) may be a consequence of persistent intrarenal
vasoconstriction. Regulators of G-protein signaling (RGSs)
are GTPase activators of heterotrimeric G proteins that can
regulate vascular tone. RGS4 is expressed in vascular smooth
muscle cells in the kidney; however, its protein levels are
low in many tissues due to N-end rule-mediated
polyubiquitination and proteasomal degradation. Here,
we define the role of RGS4 using a mouse model of IRI
comparing wild-type (WT) with RGS4-knockout mice. These
knockout mice were highly sensitized to the development
of renal dysfunction following injury exhibiting reduced
renal blood flow as measured by laser-Doppler flowmetry.
The kidneys from knockout mice had increased renal
vasoconstriction in response to endothelin-1 infusion ex vivo.
The intrinsic renal activity of RGS4 was measured following
syngeneic kidney transplantation, a model of cold renal IRI.
The kidneys transplanted between knockout and WT mice
had significantly reduced reperfusion blood flow and
increased renal cell death. WT mice administered MG-132
(a proteasomal inhibitor of the N-end rule pathway) resulted
in increased renal RGS4 protein and in an inhibition of renal
dysfunction after IRI in WT but not in knockout mice.
Thus, RGS4 antagonizes the development of renal
dysfunction in response to IRI.
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Acute kidney injury affects almost 15% of patients admitted
to the hospital in the United States and results in significant
mortality and morbidity.1–3 Acute kidney injury in humans is
often due to episodic hypotension, such as that which occurs
with septic, hypovolemic, or cardiogenic shock. In shock,
renal hypoperfusion is followed by reperfusion in surviving
patients. Deceased donor organ transplants are also subjected
to ischemic kidney injury.4 These forms of kidney ische-
mia–reperfusion injury (IRI) often result in acute renal
dysfunction due to acute tubular necrosis. Although the
intrarenal release of reactive oxygen species is considered one
cause of reperfusion injury, persistent reductions in renal
blood flow and increased renal vascular resistance after
reperfusion may also contribute to renal dysfunction.5
The concentration of ligands that bind to transmembrane
G protein-coupled receptors, including thromboxane A2,
angiotensin II, and endothelin-1, is increased in ischemic
kidney injury.6,7
Vascular smooth muscle cells regulate renal blood flow
in a manner that depends on their contractile state.
Endothelin-1 and angiotensin II regulate vascular tone by
binding to transmembrane receptors on smooth muscle
cells.8,9 Endothelin-1 acts on the vascular bed of the kidney
and this contributes to vaso-occlusive crisis, cyclosporine
nephrotoxicity, and experimental IRI.10–13 Endothelin-1
binds to endothelin-1A G protein-coupled receptors in
vascular smooth muscle cells and activates the Gaq subunit
which, in turn, directly stimulates phospholipase Cb to
generate inositol triphosphate (IP3), which opens IP3-
dependent calcium channels resulting in vasoconstriction.14
G protein a-subunits have intrinsic GTPase activity that is
relatively weak.15 This intrinsic GTPase activity results in the
hydrolysis of GTP to guanosine diphosphate, resulting in
deactivation of the a-subunit and in reformation of the
heterotrimer with bg-subunits. Regulators of G-protein
signaling (RGSs) proteins are GTPase-activating proteins
that promote the deactivation of GTP-bound a-subunits by
stabilizing the transition state.15,16 RGS4 is a relatively small
RGS family member that has a 120 amino-acid RGS box with
GTPase-activating protein activity.17–22 RGS4 abundance is
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limited by N-end pathway-mediated polyubiquitination and
proteasomal degradation.23,24 RGS4 is a vascular-associated
protein; however, its expression outside the brain remains
controversial.25 RGS4 has the ability to promote deactivation
of both Gq/11 and Gi/o family members dependent on the
cell type where it acts.20,26,27
We have previously generated mice with targeted disrup-
tion of the gene encoding RGS4 (R4KO).28 RGS4-knockout
(R4KO) mice had normal blood pressure and renal function
at baseline along with several other hemodynamic para-
meters. In previous work, we showed that R4KO mice
were sensitized to cyclosporine A-induced nephrotoxicity.28
Cyclosporine A-treated R4KO mice rapidly developed severe
renal dysfunction and exhibited increased mortality than did
cyclosporine A-treated wild-type (WT) mice. Administration
of the endothelin-1 antagonist bosentan to cyclosporine
A-treated R4KO mice reversed the development of renal
failure and significantly reduced mortality.28
To determine whether R4KO mice are also sensitized to a
more generalized form of kidney injury, we used a murine
model of IRI. Using this model system, we performed
experiments that suggest that R4KO mice are highly
sensitized to IRI of the kidney. Owing to the potential
therapeutic benefit of enhancing RGS activity during renal
injury, it is important to understand the role of RGS4 in
acute renal ischemia.
RESULTS
RGS4-null mice are sensitized to renal IRI
The localization and intensity of RGS4 expression outside the
central nervous system are not well established.25 To precisely
determine the expression pattern of RGS4 in the kidney,
mice with targeted insertion of the lacZ gene encoding
b-galactosidase downstream of the promoter region of rgs4
were analyzed. The RGS4 reporter mouse (rgs4tm1Dgen/þ )
showed intense X-gal staining in the arterial vasculature of
the kidney with minimal staining in tubular structures
(Figure 1a and b).
To model renal IRI in genetically modified mice, we
initially performed warm ischemia–reperfusion injury (IRI)
using a technique previously described in rats and mice.29,30
Both plasma urea and serum creatinine levels in R4KO mice
were significantly elevated than in WT mice 24 h after
ischemic injury (Figure 2a and b).
To determine whether increased plasma urea and
creatinine levels in R4KO mice after IRI were associated with
intrarenal injury, the kidney tissue was evaluated using
histological methods 24 h after surgery. The R4KO kidneys
exhibited massive tubular injury most prominently in the
cortico-medullary junction 24 h after IRI, whereas the WT
kidneys exhibited moderate injury measured by standardized
tubular injury scoring (Figure 3).
To further evaluate renal injury after ischemia–reperfusion
surgery, animal survival was monitored for 15 days in R4KO
and WT mice. R4KO mice exhibited significantly reduced
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Figure 1 |X-gal staining in the RGS4 reporter mouse
(rgs4tm1Dgen/þ ). (a) X-gal staining is concentrated in the nuclear
compartment in arterial vascular smooth muscle cells of the
kidney. (b) The tissue was co-stained with anti-a-smooth muscle
actin (a-SM actin) mouse antibody to confirm that b-galactosidase
is expressed in vascular smooth muscle cells. 40,6-diamidino-2-
phenylindole (DAPI) staining verified cell viability. Bar¼ 20 mm.
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Figure 2 |Rgs4/ mice are susceptible to renal
ischemia–reperfusion injury (IRI). (a) Plasma urea was measured
in R4KO (R4K) (n¼ 10) and wild-type (WT) congenic mice (n¼ 10).
Plasma urea was increased in R4K after IRI compared with other
groups by one-way ANOVA pairwise comparison: composite
P¼ 4 105; WTþ Sham (n¼ 5) vs R4Kþ Sham
(n¼ 5)¼ *(P¼ 0.68); R4Kþ Sham (n¼ 5) vs R4Kþ IRI
(n¼ 5)¼ w(P¼ 2 104); WTþ IRI vs R4Kþ IRI¼z(P¼ 3 104).
(b) Plasma creatinine was measured in R4KO (R4K) (n¼ 10) and
wild-type congenic mice (n¼ 10). Plasma creatinine was increased
in R4K after IRI compared with other groups by one-way
independent ANOVA pairwise comparison: composite
P¼ 1 1010; WTþ Sham (n¼ 5) vs R4Kþ Sham
(n¼ 5)¼ *(P¼ 0.7); WTþ Sham (n¼ 5) vs WTþ IRI
(n¼ 5)¼ **(P¼ 1 104); R4Kþ Sham (n¼ 5) vs R4Kþ IRI
(n¼ 5)¼ w(P¼ 1 1011); WTþ IRI vs R4Kþ IRI¼z(P¼ 1 107).
ANOVA, analysis of variance; R4KO, RGS4 knockout; RGS, regulator
of G-protein signaling.
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survival after IRI surgery than did WTmice. Fifteen days after
IRI, five of eight WT animals were alive, but all eight R4KO
mice died within 7 days of surgery (Mantel–Cox log-rank
analysis Po0.0001) (Figure 4).
Increased renal vasoconstriction after IRI in R4KO mice
The increased sensitivity of R4KO mice to renal IRI could be
due to vasomotor or renal tubular abnormalities as RGS
proteins are known to be expressed in both vascular smooth
muscle cells and tubular epithelial cells.31 To address this
mechanistic issue, we examined blood flow using laser
Doppler in the minutes after kidney reperfusion.32–34 The
recovery of renal blood flow immediately after pedicle clamp
release was impaired in the R4KO kidneys (Figure 5).
Therefore, persistently reduced R4KO intrarenal blood flow
after IRI may be responsible for the abnormal phenotype.
R4KO mice are sensitized to ligand-stimulated renal
vasoconstriction and Gq activation
RGS4 promotes deactivation of Gaq/11 and Gai/o and
is expressed in vascular smooth muscle cells.19,20,25 Our
previous work implicated a cyclosporine-dependent release
of endothelin-1 in the renal vasculature. Therefore, we
hypothesized that R4KO mice would be sensitized to the
vascular effects of ligands that activate Gaq, such as
endothelin-1. The R4KO and WT kidneys were rapidly
isolated and placed on an ex vivo perfusion apparatus capable
of measuring intrarenal perfusion pressures. Endothelin-1
(50 pmol) was administered by bolus injection into the renal
artery and perfusion pressures were measured. In WT mice,
renal artery perfusion pressure increased and peaked 6min
after endothelin-1 injection, but rapidly decreased to baseline
by 28min after injection. In contrast, the R4KO kidneys
exhibited a sustained increase in renal artery perfusion
pressures after endothelin-1 administration that declined
more gradually (Figure 6a).
To confirm that the R4KO kidneys were sensitized to
Gq-mediated signaling in response to endothelin-1 infusion,
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Figure 3 |Absence of RGS4 leaves the kidney susceptible to
acute tubular necrosis due to ischemia–reperfusion injury
(IRI). Periodic acid-Schiff-stained kidney sections from (a, c)
wild-type and (b, d) RGS4-knockout mice underwent sham
surgery or IRI. (d) The R4Kþ IRI kidneys had an increased tubular
injury score of 47±6%, 2.6-fold more tubular damage than
WTþ IRI (**P¼ 2 108, Student’s t-test). WTþ IRI vs
WTþ S,*Po0.001. Kidney sections were processed after 24 h of
reperfusion and were evaluated for tubule flattening, necrosis,
apoptosis, or presence of casts. Bar¼ 100 mm. R4KO, RGS4
knockout; RGS, regulator of G-protein signaling; WT, wild type;
WTþ S, wild congenic control mice undergoing sham surgery.
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Figure 4 | Increased mortality after standardized
ischemia–reperfusion injury (IRI). Rgs4/ mice (n¼ 8) versus
congenic wild-type (WT) controls (n¼ 8) underwent the same
surgical procedure. Survival after IRI was monitored for 15 days
(Mantel–Cox log-rank test, P¼ 1 106). RGS, regulator of
G-protein signaling.
Kidney International (2011) 80, 263–271 265
A Siedlecki et al.: RGS4 inhibits renal IRI o r ig ina l a r t i c l e
we measured renal IP3 levels. Ex vivo-perfused WTand R4KO
kidneys were treated with endothelin-1 or buffer for 10min.
Endothelin-1-treated R4KO kidneys had significantly
higher IP3 levels than did endothelin-1-treated WT kidneys
(Figure 6b).
RGS4 has intrinsic renal activity in an in vivomodel of cold IRI
To identify the renal-specific effect of RGS4 in vivo, we
performed syngeneic kidney transplantation surgery, a model
of cold renal IRI, between R4KO and WT mice. This model
allowed us to exclude the possibility that systemic factors in
R4KO mice were responsible for the abnormal renal
vasomotor tone, such as circulating systemic factors or input
from the autonomic nervous system.35,36 The kidneys were
surgically isolated from WT and R4KO mice and kept in
buffer for 3 h before implantation into WT-recipient mice.
In a sub-population of kidneys kept in cold storage, organs
were cannulated and arterial perfusion pressure was mea-
sured in isolation (Supplementary Figure S1 online). Perfusion
pressure stabilized in all kidneys after 15min. Steady-state
perfusion pressure was increased in isolated, procured R4KO
kidneys. Renal blood flow in the transplanted R4KO kidneys
was dramatically reduced than in the transplanted WT
kidneys in the early organ reperfusion phase (Figure 7).
To determine whether the reduced blood flow observed in
the transplanted R4KO kidneys was associated with intrarenal
injury, kidney sections were evaluated by histological
methods 12 h after transplantation into WT mice. The
R4KO kidneys exhibited increased tubular cell death most
prominently in the cortico-medullary junction, whereas the
WT kidneys exhibited minimal tubular cell death (Figure 8).
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Figure 6 |An enhanced response to endothelin-1 was
observed in the RGS4-null kidneys. (a) Persistent
vasoconstriction observed in ex vivo-perfused R4KO kidneys after
infusion of endothelin-1. The kidneys were isolated from wild-type
or R4KO mice and placed on a perfusion apparatus with constant
monitoring of perfusion pressure. The kidneys were administered
a bolus injection of saline vehicle (V) or endothelin-1 (E), and renal
perfusion pressures were monitored for 45min. Endothelin bolus
(50 pmol) was injected to the ex vivo kidney perfusion system.
After 18±2min, the rate change of pressure (mmHg) per unit of
time (seconds) was distinct between congenic controls (WTþ E)
(n¼ 5) and R4KO exposed to endothelin (R4Kþ E) (n¼ 5). ANOVA
pairwise comparison: composite P¼ 2 1010. Average decrease
in pressure/change in time (dp/dt) was 0.37±0.02mmHg/min
in R4KO vs 0.73±0.01mmHg/min in WT. (b) Increased inositol
triphosphate accumulation in the R4KO kidneys in response to
bolus injection of endothelin-1. The kidneys were isolated,
perfused, and administered vehicle or endothelin-1 as described
above. IP3 was increased in R4KO exposed to endothelin (R4Kþ E)
(n¼ 5) compared with wild-type congenic mice (WTþ E) (n¼ 5)
by one-way ANOVA pairwise comparison: composite
P¼ 2 1012; WTþV (n¼ 5) vs R4KþV (n¼ 5)¼ *(P¼ 0.16);
R4Kþ E (n¼ 5) vs WTþ E (n¼ 5)¼ w(P¼ 4 109); R4Kþ E vs
R4KþV (n¼ 5)¼z(P¼ 1 109). ANOVA, analysis of variance; IP3,
inositol triphosphate; R4KO, RGS4 knockout; RGS, regulator of
G-protein signaling; WT, wild type.
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Figure 5 |Reduced recovery of renal blood flow was observed
in R4KO mice after renal ischemic injury. Renal blood flow in
the wild-type (WT) and R4KO (R4K) kidneys was analyzed using a
laser-Doppler flowmeter placed on the mid-pole of the left kidney
in the minutes after the ischemic phase of IRI surgery or after a
sham operation (S). Blood flow measurement was obtained in
wild congenic control mice undergoing sham surgery (WTþ S),
R4KO undergoing sham (R4Kþ S), congenic control mice
undergoing ischemia–reperfusion injury (WTþ IRI), or R4KO
undergoing ischemia–reperfusion injury (R4Kþ IRI). ANOVA
pairwise comparison: *, composite P¼ 1 1011. Systemic blood
pressure was measured simultaneously using a tail-cuff volume
pressure measurement device. ANOVA, analysis of variance; IRI,
ischemia–reperfusion injury; R4KO, RGS4 knockout; RGS, regulator
of G-protein signaling.
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Role of RGS4 proteasomal degradation in renal IRI response
RGS4 protein levels are minimized in many cell types as a
result of N-end rule pathway-mediated proteolysis.23,24
We hypothesized that acute treatment of WT mice with
inhibitors of the N-end rule pathway-mediated proteasomal
degradation would result in RGS4 protein upregulation
and that increased RGS4 protein levels would lead to
resistance to IRI.
To increase RGS4 protein levels in the kidney, we treated
mice with the synthetic peptide aldehyde proteasomal
inhibitor, MG-132, and then subjected animals to IRI.
MG-132 treatment of WT resulted in increased RGS4 protein
levels and reduced plasma urea 24 h after IRI (Figure 9).
Although cytosolic RGS4 levels are distinctly sensitive to
proteasomal inhibition, the half-life of other beneficial
proteins may also persist. To determine whether the effect
of MG-132 on the response to renal IRI was specifically due
to stabilization of the RGS4 protein, we used R4KO mice in
similar experiments. Administration of MG-132 to R4KO
mice did not have a beneficial effect on IRI-mediated renal
dysfunction (Figure 9b).
DISCUSSION
Acute renal failure frequently occurs in the hospital setting
and is associated with a high incidence of morbidity,
unremitting kidney injury, and death.37 The extent of kidney
injury is dependent on the duration of ischemia and has
been incorporated into risk assessment scores because of the
prognostic value of tissue ischemia.38–40
RGS proteins are hypothesized to have a major role in
the regulation of vascular tone throughout the body by
modulating the activation of heterotrimeric G proteins.19,20
The role of RGS4 in the regulation of vascular tone has not
been studied previously. This is in part due to the low RGS4
mRNA levels in many tissues outside the brain, except under
periods of stress or inflammation.17,25,41,42 Furthermore,
basal protein levels for RGS4 in most tissues are very low.
This is likely a consequence of constitutive N-end rule-
mediated proteasomal degradation23,24 that can be manipu-
lated to increase RGS4 levels in greater proportion than other
vascular-associated proteins, such as RGS2 and RGS5.24 In
the N-end rule pathway, the amino-terminal methionine of
RGS4 is removed by a methionine aminopeptidase, and the
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Figure 7 |Reduced renal blood flow in kidney transplants with
RGS4 deletion. Renal blood flow was measured immediately
after transplant anastomosis in wild-type (WTþ TX) and
RGS4-knockout (R4Kþ TX) kidney allografts. The rate change
of reperfusion blood flow was depressed in R4K allografts
compared with WT allografts during reperfusion (*P¼ 1 1011).
Systemic blood pressure was measured simultaneously using
tail-cuff volume pressure measurement device. RGS, regulator
of G-protein signaling.
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Figure 8 |Cell death after syngeneic renal transplantation.
TdT-mediated dUTP nick-end labeling (TUNEL) assay staining
performed on tissue sections from the (a, c) wild-type and (b, d)
RGS4-knockout kidneys obtained after procurement or 12 h after
allograft implantation, respectively. (e) Few TUNEL-positive cells
(green) were seen in the sham WT or R4K kidneys after
procurement; however, there were 5.3-fold more TUNEL-positive
cells in R4K donor allografts (R4Kþ TX) compared with WT
animals undergoing the same procedure (WTþ TX)
(**P¼ 1 105). Increased cell death was present in wild-type
mice undergoing surgery (WTþ TX) compared with shams
(WTþ S) (*P¼ 0.012, Student’s t-test). Bar¼ 25mm. RGS, regulator
of G-protein signaling; WT, wild type.
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uncovered second residue, a cysteine, is first oxidized and
then arginylated, before RGS4 is poly-ubiquitinated and
degraded by the proteasome.23,24,43,44 Dependence on oxygen
or nitric oxide for modification of the cysteine before
arginylation suggests that kidney ischemia may result in
RGS4 protein stabilization.
Heterotrimeric G-protein signaling is a key feature in the
physiological regulation of vascular tone. In response to
ischemia, vascular endothelial cells in the kidney are injured,
leading to the release of endothelin-1, angiotensin II,
thromboxane A2, adenosine, and other ligands that stimulate
seven transmembrane Gq protein-coupled receptors in
smooth muscle cells. Serum concentrations of these ligands
persist during the reperfusion phase and prolong the
ischemic event beyond the period of extrinsic reduction in
renal blood flow. RGS proteins may have a critical role
in extinguishing the persistent intracellular signal initiated by
extracellular G protein-coupled receptor ligands.
In previous work, we generated mice lacking RGS4 and
found that R4KO mice exhibited a markedly abnormal
response to cyclosporine, with reduced renal blood flow,
increased renal dysfunction, and mortality.28 In the current
work, we found that R4KO mice were highly sensitized
to renal IRI. Isolated kidney experiments and syngeneic renal
transplantation suggest that this sensitivity is due to the
intrinsic renal function of RGS4. The absence of RGS4 may
prolong G protein-mediated vasoconstriction in the renal
vasculature. This is evident in both our ex vivo and in vivo
model systems and is consistent with the known function of
RGS proteins as a deactivator of the G-protein signaling
cascade. RGS proteins enhance GTPase activity of the Ga
subunit to which they bind. Our studies are the first to
identify RGS protein activity in the renal vasculature linked
to physiological function. RGS2 was the first RGS protein
recognized to influence vascular hemodynamics in a
mammalian model system. RGS2-knockout animals exhibit
baseline hypertension and increased collagen matrix deposi-
tion in elastic arteries of the kidney45 in contrast to R4KO,
which are normotensive.28 Similar to R4KO animals,
RGS2-knockout animals exhibit end-organ failure only after
significant hemodynamic perturbation is initiated. Cardio-
myocytes in the hearts of RGS2-knockout animals are highly
responsive to supraphysiological cardiac afterload and
generate cardiac hypertrophy out of proportion to that
identified in WT controls.46 RGS2 expression has not been
identified in the renal vasculature, suggesting that RGS
proteins have discriminant activity in diverse vascular beds of
the mammalian system. Agents that promote RGS4 expres-
sion, RGS4 protein stabilization, or those that antagonize
Gq/11 signaling in renal vascular smooth muscle cells are
likely to reduce the development and progression of
acute kidney injury after IRI. Agents that block the N-end
rule pathway are likely to stabilize the RGS4 protein and
may have salutary effects on kidney function in the setting
of IRI.
MATERIALS AND METHODS
Mice with targeted disruption of rgs4 genes
Murine 129/SvJ embryonic stem cells with targeted disruption of
one allele of the rgs4 gene were generated as described previously.28
Homozygous R4KO mice in the C57Bl/6J genetic background
(R4KO) were bred and found to be viable and fertile. All researches
involving the use of mice were performed in strict accordance with
protocols approved by the Animal Studies Committee of Washing-
ton University School of Medicine.
Construction of targeting vector and generation of
RGS4-null mice
RGS4-null mice expressing b-galactosidase under control of the
RGS4 promoter were generated by Deltagen (San Mateo, CA) using
techniques described previously.47 In brief, a genomic fragment
including protein coding regions of the RGS4 gene was isolated
from a mouse genomic library and subcloned into the SK() vector.
A segment of the protein coding region was replaced with an
IRES-lacZ reporter and neomycin (G418)-resistance cassette.
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Figure 9 |Proteasomal inhibition prevents IRI in the kidneys
by stabilizing RGS4 protein levels. (a) Administration of MG-132
(M) to wild-type (WT) mice results in increased renal RGS4 protein
levels. Immunoblot is representative of five separate experiments.
(b) Administration of MG-132 (M) to WT mice, but not RGS4-
knockout mice (R4K), inhibits renal IRI. Twenty-four hours after IRI
surgery, blood was obtained from mice for determination of
plasma urea nitrogen levels. For each group, five animals were
analyzed by ANOVA analysis. *P¼ 5 108 versus R4Kþ Sham;
wP¼ 1 1011 versus R4Kþ Sham. ANOVA, analysis of variance;
IRI, ischemia–reperfusion injury; RGS, regulator of G-protein
signaling.
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This mutation was designed to produce a loss-of-function mutation
by deletion of an amino-acid sequence.
Murine warm renal ischemia–reperfusion surgery
Adult male WT and R4KO mice were anesthetized with a mixture of
xylazine (16mg/kg) and ketamine (80mg/kg). We determined that
R4KO mice were overly sensitive to simultaneous bilateral renal
pedicle clamping. Therefore, a sequential pedicle clamp technique
was used. First, a left flank incision was made and the kidney
exposed. A pedicle clamp was placed on the left main renal artery
and the clamp was adjusted so that renal blood flow was reduced to
0–1.5ml/min per 100 g using a laser-Doppler flowmeter. After
25min, the clamp was released and removed. The pedicle clamp was
then placed and tightened on the main right renal artery for 25min
with confirmation by the laser-Doppler flowmeter that the right
renal blood flow was reduced. After 25min, the clamp was released
and removed. The incisions were closed and the animal was allowed
to recover.
Ex vivo-isolated kidney perfusion
Our ex vivo kidney perfusion technique is an adaptation of the
original protocol described by Stegbauer et al.48 We modified the
technique for unilateral isolation of the left kidney to reduce
warm ischemia time. Once extracted, the kidney is maintained at a
constant pressure using a programmable peristaltic pump and an
in-line pressure monitor further detailed in the Supplementary
Methods section.
In a subset of animals designated for kidney procurement and
transplantation, organs were procured and instead cannulated for
ex vivo measurement of perfusion pressure. Immediately after
extraction, organs were flushed with an organ preservation buffer
and stored for 3 h at 2 1C and then analyzed using a ex vivo kidney
perfusion apparatus. Flow rate was gradually increased over the first
2min of perfusion and then kept constant at 2.5ml/min per g while
perfusion pressure was measured.
Syngeneic renal transplantation
At 12 weeks of age, donor mice were randomized to undergo left
nephrectomy. The surgical operator was blinded to the animal’s
genotype. Mice were anti-coagulated with systemic heparin
(1000Units/kg). Mice were anesthetized with isoflurane. Aortic
branches including the spermatic arteries and lumbar arteries were
ligated with suture. Ligatures were placed around the aorta proximal
to the left renal artery and proximal to the femoral artery
bifurcation. Aortic ligation was then performed with dissection of
the left kidney from perinephric fascia. The ureter was kept intact
along with a 10-mm diameter bladder patch. The procured kidney
was immediately flushed with chilled Collins organ preservative
buffer. Recipient mice at 20 weeks of age, weighing between 25 and
30 g, were selected as syngeneic renal allograft recipients. Microvessel
clamps with 60 g/mm2 of force were placed at the transverse level
inferior to the spermatic arteries and proximal to the femoral artery
bifurcations. Clamping these locations helps to avoid the need to
ligate arterial branches and reduces the number of lumbar vein
ligations. An aortotomy was performed using a curved 6-0 surgical
needle. Orifice diameter was enlarged using iridectomy scissors to
match the diameter of the donor allograft’s artery. Two running
stitches were used for arterial anastomosis. Venotomy was used to
perform a similar technique for venous anastomosis. Donor
venotomy was made proximal to the outflow of the renal vein.
Two running stitches were used for venous anastomosis.
The microvessel clamps were removed. The contents of the
recipient’s bladder were aspirated using a 31-G needle. The bladder
wall was incised to a diameter matching the donor’s bladder patch.
Two running stitches were used to anastomose the bladder walls.
The abdomen was rinsed with sterile normalized saline. The fascial
and then skin layers were closed with 6-0 silk, and the animal was
allowed to recover in a clean, isolated cage.
Renal histology and morphometry
Mice were weighed and the kidneys isolated. Sections of 5-mm
thickness were microtome sectioned and exposed to Schiff ’s reagent
to perform periodic acid-Schiff staining. Tubular injury scoring was
completed on each kidney at the maximum longitudinal section in
the sagittal plane and is further detailed in the Supplementary
Methods section. Terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labeling assay was performed. For each specimen,
10 consecutive fields at a magnification of  200 were analyzed for
green fluorescent nuclear staining, which designated terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling
positivity. X-gal staining and co-staining with a-smooth muscle
actin monoclonal mouse antibody (Abcam, Cambridge, MA) was
performed by the Washington University histology core. Frozen
tissue sections were microtomed (6 mm) and formalin fixed for
10min in preparation for X-gal staining. Co-staining with the
a-smooth muscle actin monoclonal mouse antibody was then
performed. Finally, DAPI (40,6-diamidino-2-phenylindole) solution
(Molecular Probes, Eugene, OR) staining verified cell viability DAPI
staining.
Protein analysis
Cytosolic protein lysates from the kidney tissue were obtained as
described previously.28 In brief, the tissue was harvested from mice,
and lysates were processed in the presence of a protein lysis buffer.
Once processed, proteins bound to nitrocellulose filters were washed
and incubated with murine anti-RGS4 (Santa Cruz Biotechnology,
Santa Cruz, CA) and anti-b-actin (Sigma Aldrich, St Louis, MO).
Bands were visualized using the ECL system (GE Healthcare
Bio-Sciences, Piscataway, NJ). Densitometry was performed using
ImageJ software v1.24 (NIH, Bethesda, MD).
Inositol-1,4,5-triphosphate tissue measurement
IP3 can now be assayed directly using a radioreceptor assay (Perkin-
Elmer, Waltham, MA) avoiding indirect calculation of IP3 levels by
measurement of the activity of inositol polyphosphate precursors.49
The tissue was rapidly isolated, bivalved, snap frozen in liquid
nitrogen, and rapidly pulverized on dry ice. The pulverized tissue
was immediately resuspended in ice-cold 1mol/l trichloroacetic acid
solution, which includes 1mmol/l ethylenediaminetetraacetic acid
to chelate magnesium in order to prevent phosphatase interference
and minimize the degradation of IP3. After centrifugation, the
supernatant was removed. 1,1,2-Trichloro-1,2,2-trifluoroethane-
trioctylamine was added in 2:1 proportion for each volume of
supernatant. The aqueous layer was aspirated and stored on ice.
A working receptor/tracer solution was prepared by diluting
the concentrated receptor preparation tracer in 1:15 proportion.
The working receptor/tracer solution was thoroughly mixed in 4:1
proportion with each sample and centrifuged at 2000 g for 17min.
Samples were then decanted and resuspended with 0.15mol/l NaOH
and mixed with 5ml Ultima Gold scintillation fluid (Packard
Instruments, Meridian, CT). Scintillation counts were measured
in a Beckman scintillation counter.
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In vivo hemodynamic monitoring
Renal artery blood velocity was measured immediately after the
release of the left renal artery pedicle clamp in our model of warm
renal IRI. We used an Advanced Laser (Doppler) flowmeter
21 (ALF21, Advance, Tokyo, Japan), which measures instantaneous
fluid flow and was directly applied to the medial aspect of the left
kidney’s cortical surface at the level of the mid pole. The timing of
measurement after the first pedicle clamp release avoided the
possibility of pre-conditioning. Mice were anesthetized with a
mixture of xylazine (16mg/kg) and ketamine (0.080mg/g). A sham
procedure was performed exposing the right kidney but maintaining
its blood supply. After renal transplantation, the same technique was
used to measure renal blood flow. Control blood flow in transplant
recipients was performed on the right native kidney after transplant
anastomoses were complete.
A volume pressure recording device (Kent Scientific, Torrington,
CT) was used for tail cuff blood pressure measurements of mice
during and after surgical procedures. Five cycles were completed per
animal and then averaged.
MG-132 administration
The synthetic peptide aldehyde proteasomal inhibitor, MG-132, was
administered 48 and 24 h before surgery. Mice were treated with
MG-132 (2mg/kg) or vehicle (dimethyl sulfoxide) (100 ml) 48 h
before IRI. Mice were then re-dosed with MG-132 (1mg/kg) or
vehicle (50ml) 24 h before surgery.
Quantitation of body fluid constituents
Laboratory values were obtained 24 h after warm IRI was performed.
Levels of blood plasma urea nitrogen and serum creatinine were
measured in the Department of Comparative Medicine Diagnostic
Laboratory at the Washington University School of Medicine.
Survival studies
Mice were monitored after warm IRI on a perpetual 8-h interval.
Mice that were determined moribund after one time interval were
monitored more frequently on a 4-h basis. Mice that remained
moribund after one 8-h interval and then one 4-h hour interval were
killed. Mice were defined as moribund if they were immobile, or
lethargic with raised hair, or lethargic and tremulous.
Statistical analysis
All data are presented as mean values±s.e.m. Static group analysis
was performed using SigmaStat 3.1 (Systat Software, San Jose, CA).
Statistical relationships were determined by Student’s T-test. One-
way ANOVA (analysis of variance) was used in comparisons of more
than two groups, and Holm–Sidak pairwise comparisons were
calculated between groups. Kaplan–Meier survival curves and
Mantel–Cox log-rank analysis were performed using SPSS version
13.0 (SPSS, Chicago, IL).
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